A wave of Chinese companies have halted domestic listing plans, filings show, as the country’s biggest coronavirus outbreak in two years hampered due diligence and information gathering, affecting an estimated $9 billion-plus in fundraising.
Learn more : Covid-19 Outbreaks Stall Shanghai, Shenzhen IPOs Worth $9bn